The Journal of Experimental Medicine,
Journal Year:
2022,
Volume and Issue:
219(12)
Published: Sept. 23, 2022
Individuals
who
receive
a
third
mRNA
vaccine
dose
show
enhanced
protection
against
severe
COVID-19,
but
little
is
known
about
the
impact
of
breakthrough
infections
on
memory
responses.
Here,
we
examine
antibodies
that
develop
after
or
fourth
antigenic
exposure
by
Delta
Omicron
BA.1
infection,
respectively.
A
to
antigen
increases
number
B
cells
produce
with
comparable
potency
and
breadth
dose.
infection
increased
variant-specific
plasma
antibody
cell
However,
did
not
increase
overall
frequency
their
general
compared
In
conclusion,
elicits
strain-specific
responses
in
cells.
contrast,
effects
are
limited
effect
antibodies.
The
results
suggest
boosting
compartment
may
be
limited.
Nature,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 29, 2025
Abstract
Since
the
onset
of
pandemic,
many
SARS-CoV-2
variants
have
emerged,
exhibiting
substantial
evolution
in
virus’
spike
protein
1
,
main
target
neutralizing
antibodies
2
.
A
plausible
hypothesis
proposes
that
virus
evolves
to
evade
antibody-mediated
neutralization
(vaccine-
or
infection-induced)
maximize
its
ability
infect
an
immunologically
experienced
population
1,3
Because
viral
infection
induces
antibodies,
may
thus
navigate
on
a
dynamic
immune
landscape
is
shaped
by
local
history.
Here
we
developed
comprehensive
mechanistic
model,
incorporating
deep
mutational
scanning
data
4,5
antibody
pharmacokinetics
and
regional
genomic
surveillance
data,
predict
variant-specific
relative
number
susceptible
individuals
over
time.
We
show
this
quantity
precisely
matched
historical
variant
dynamics,
predicted
future
dynamics
explained
global
differences
dynamics.
Our
work
strongly
suggests
ongoing
pandemic
continues
shape
immunity,
which
determines
variant’s
transmit,
defining
fitness.
The
model
can
be
applied
any
region
utilizing
allows
contextualizing
risk
assessment
provides
information
for
vaccine
design.
Science Immunology,
Journal Year:
2022,
Volume and Issue:
7(77)
Published: Sept. 20, 2022
BNT162b2-vaccinated
individuals
after
Omicron
BA.1
breakthrough
infection
have
strong
serum-neutralizing
activity
against
BA.1,
BA.2,
and
previous
SARS-CoV-2
variants
of
concern
(VOCs)
yet
less
the
highly
contagious
sublineages
BA.4
BA.5
that
displaced
variants.
Because
latter
are
derived
from
we
characterized
COVID-19
mRNA
vaccine
triple-immunized
who
experienced
BA.2
infection.
We
demonstrate
sera
these
broadly
neutralizing
VOCs
all
tested
sublineages,
including
BA.2-derived
BA.2.12.1
BA.4/BA.5.
Furthermore,
applying
antibody
depletion,
showed
neutralization
BA.4/BA.5
by
convalescent
is
driven
to
a
considerable
extent
antibodies
targeting
N-terminal
domain
(NTD)
spike
glycoprotein.
However,
depends
exclusively
on
receptor
binding
(RBD).
These
findings
suggest
exposure
in
contrast
glycoprotein,
triggers
substantial
NTD-specific
recall
responses
vaccinated
thereby
enhances
sublineages.
Given
current
epidemiology
with
predominance
such
as
rapidly
ongoing
evolution,
helped
inform
development
our
BA.4/BA.5-adapted
vaccine.
Cell Reports,
Journal Year:
2022,
Volume and Issue:
42(1), P. 111903 - 111903
Published: Dec. 14, 2022
Variants
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
have
caused
successive
global
waves
infection.
These
variants,
with
multiple
mutations
in
the
spike
protein,
are
thought
to
facilitate
escape
from
natural
and
vaccine-induced
immunity
often
increase
affinity
for
ACE2.
The
latest
variant
cause
concern
is
BA.2.75,
identified
India
where
it
now
dominant
strain,
evidence
wider
dissemination.
BA.2.75
derived
BA.2
contains
four
additional
receptor-binding
domain
(RBD).
Here,
we
perform
an
antigenic
biophysical
characterization
revealing
interesting
balance
between
humoral
evasion
ACE2
receptor
affinity.
increased
9-fold
compared
BA.2;
there
also
immune
serum,
particularly
that
induced
by
Delta
infection,
which
may
explain
rapid
spread
India,
a
high
background
appears
be
prioritized
over
greater
escape.
The Journal of Experimental Medicine,
Journal Year:
2022,
Volume and Issue:
219(12)
Published: Sept. 23, 2022
Individuals
who
receive
a
third
mRNA
vaccine
dose
show
enhanced
protection
against
severe
COVID-19,
but
little
is
known
about
the
impact
of
breakthrough
infections
on
memory
responses.
Here,
we
examine
antibodies
that
develop
after
or
fourth
antigenic
exposure
by
Delta
Omicron
BA.1
infection,
respectively.
A
to
antigen
increases
number
B
cells
produce
with
comparable
potency
and
breadth
dose.
infection
increased
variant-specific
plasma
antibody
cell
However,
did
not
increase
overall
frequency
their
general
compared
In
conclusion,
elicits
strain-specific
responses
in
cells.
contrast,
effects
are
limited
effect
antibodies.
The
results
suggest
boosting
compartment
may
be
limited.